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Introduction
Candida species are the most prevalent fungal pathogens in 
human, causing opportunistic fungal infection worldwide. 
Fungal infections, including candidiasis represent serious 
threats, particularly in immunocompromised patients 
(1,2). Candida species such as Candida albicans, Candida 
glabrata, Candida parapsilosis, Candida tropicalis and 
Candida krusei account for ∼90% of invasive candidiasis 
(2,3). C. albicans is still the most common pathogen; its 
incidence is declining with the increasing prevalence of 
other species (2,4).
There are significant expansions of virulence factors, 
such as the ability of this fungus to switch from yeast 
to filamentous forms (true hyphae or pseudohyphae), 
molecules which mediate adhesion to and invasion into 
host cells, phenotypic switching (white-opaque transition), 
contact sensing and thigmotropism, production of 
tissue-damaging hydrolytic enzymes such as proteases, 
phospholipases and haemolysin, biofilm formation and 
a range of fitness attributes in pathogenic species (3,5,6).
Arguably the best studied member of the Candida species in 
terms of pathogenesis is C. albicans which has a specialized 
set of adhesins. One important adhesin of C. albicans is 
Hwp1, hypha-associated GPI-linked protein; this adhesin 
serves as a substrate for mammalian transglutaminases 
and induces a covalent bond between hyphae and the host 
cell. Hwp1 also plays a complementary role in biofilm 
formation. C. albicans biofilms readily forms on any biotic 
or abiotic moist surfaces. A biofilm is defined a complex 
three-dimensional structured microbial community and 
displays extensive spatial heterogeneity. The complex 
architecture of biofilms, the effects of the biofilm matrix, 
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Introduction: Candidiasis-associated biofilm formed by Candida species complicates treatment 
and contributes to unacceptable high mortality rates. We performed the aqueous and ethanol 
extracts of the different parts of Malva sylvestris, Dorema aucheri, Ferulago angulata and Citrullus 
colocynthis plants to identify best plant extract that inhibits growth of Candida albicans or Candida 
krusei, and conducted a series of follow-up studies to examine the inhibitors of C. albicans biofilm 
formation of the identified plant extract.
Methods: The antifungal activities of the aqueous and ethanol extracts of the different parts of 
M. sylvestris, D. aucheri, F. angulata and C. colocynthis plants were evaluated in vitro using disk 
diffusion test and broth microdilution test against C. albicans and C. krusei. The crystal violet assay, 
morphological response and expression pattern of hyphal wall protein 1 (HWP1) gene were carried 
out to investigate the biofilm-inhibitory properties of the best plant extract tested in C. albicans.
Results: The screen identified ethanol extract of M. sylvestris root that largely represented antifungal 
activity among the tested extracts. M. sylvestris root inhibited C. albicans biofilm formation. Ethanol 
extract of M. sylvestris root demonstrated significant reduction in C. albicans biofilm formation (P < 
0.005). Moreover, morphological observation of ethanol extract of M. sylvestris root treated cells 
confirmed a decrease in biofilm thickness and cellular density. Finally, ethanol extract of M. sylvestris 
root displayed significant down-regulation of HWP1. 
Conclusion: These results provide proof of concept for the implementation of ethanol extract of M. 
sylvestris root as inhibitor of C. albicans biofilm formation.
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increased expression of drug efflux pump genes and 
metabolic plasticity provide protection by preventing the 
penetration of host immune factors and antifungals agents 
into the extracellular matrix in comparison to planktonic 
cells (3,6-10).
The ability of C. albicans to form drug-resistant biofilms 
has important clinical repercussions. The increasing 
prevalence of drug-resistant strains of Candida species 
necessitates searches for new targets for new antifungal 
agents. Among the alternative therapies, the use of 
natural medicines obtained from the plants has attracted 
great attention because, according to the World Health 
Organization (WHO), these would be the best source for 
obtaining a wide variety of drugs that could benefit a large 
portion of the patient population (3,9,10).
Nature has been a source of medicinal products for 
centuries, Malva sylvestris, Dorema aucheri, Ferulago 
angulata and Citrullus colocynthis are important 
traditional medicinal plants. M. sylvestris (11-13), D. 
aucheri (14,15), F. angulate (16,17) and C. colocynthis (18-
21) have inhibitory activities against microorganisms. 
Moreover, M. sylvestris (11,12), F. angulata (16) and C. 
colocynthis (19,20) extracts exhibited in vitro antifungal 
activity against some Candida species. 
Here we performed the aqueous and ethanol extracts of 
the different parts of M. sylvestris, D. aucheri, F. angulata 
and C. colocynthis plants to identify best plant extract that 
inhibits growth of C. albicans or C. krusei, and conducted 
a series of follow-up studies to examine the inhibitors of C. 
albicans biofilm formation of the identified plant extract.
Methods 
Microorganisms
Three clinical isolates of C. albicans and Candida krusei 
from Shahid Beheshti hospital, Yasooj, Iran were obtained. 
All samples were isolated from patients with systemic 
candidiasis. 
Candida albicans ATCC 10231 and C. krusei ATCC 6258 
as reference quality-control strains were employed. After 
all the isolates were identified by conventional methods 
(22) and using CHROM agar Candida medium (CHROM 
agar Company, France), all the isolates maintained as 
sterile 20% (v/v) glycerol stocks and subcultured on 
sabouraud dextrose agar with chloramphenicol (SDA, 
Difco Laboratories, Detroit, Michigan) at 35–37°C for 
24–48 hours to ensure viability and purity prior to testing.
Plants materials
Malva sylvestris, D. aucheri, F. angulata and C. colocynthis 
plants were harvested in Yasooj, Iran. Plant materials 
were transported to the lab immediately and voucher 
specimens were verified by  Zardband Pharmaceuticals 
Company, Yasooj. Different parts of the plant were 
immediately cleaned and further processed according 
to the method described by Khodavandi  et al (23), with 
slight modifications. Different parts of the plant were 
washed with sterile distilled water, sliced and dried in 
the oven for at least 2 days. One gram of tissues powder 
was mixed with 5 mL of sterile distilled water or ethanol 
and incubated at 37°C for 72 hours. The tissues extract 
was undergone a sequential extraction using soxhlet. The 
tissues extract was filter-sterilized (0.22-μm durapore, 
Millipore). 
Effect of Malva sylvestris, Dorema aucheri, Ferulago 
angulata and Citrullus colocynthis on growth of Candida 
albicans and Candida krusei
The Clinical and Laboratory Standards Institute guidelines 
(CLSI) (24) were used for the antifungal disk diffusion 
susceptibility test. The experiments were conducted in 
triplicate in 2 independent assays. The plant extracts were 
subjected to broth microdilution antifungal susceptibility 
test using CLSI reference method for yeast (25), with end 
points determined at 24 hours post inoculation. 
Effect of ethanol extract of Malva sylvestris root on 
Candida albicans biofilm formation
Candida albicans ATCC 10231 was used to form biofilm 
according to the method described by Khodavandi et al 
(26). Briefly, a suspension of C. albicans cell with a density 
of 1 × 106 cells/mL was added to 100 μL of plant extract 
at different concentrations based on minimum inhibitory 
concentration (MIC) (1/4 MIC, 1/2 MIC, 1 MIC and 2 
MIC) using 96-well microplate (Brand 781660, Wertheim, 
Germany) and incubated at 35°C for 90 minutes. 
Subsequently, the mixture was incubated at 35°C for 24 
hours with gentle shaking. 
Quantitative and qualitative analysis 
The cultures were used for quantitative and qualitative 
analysis using crystal violet (CV) assay and morphological 
response. The protocol of CV assay by Khodavandi et al 
(26) was adopted. The biofilm was fixed for 15 minutes 
by adding 100 μL of 99% methanol to each well and then 
the supernatants were ejected. Further, the cells were air-
dried and then stained with CV solution (1:50 from stock 
solution, Sigma). The extra CV was removed and the 
wells were filled with 150 μL of acetic acid 33% (Sigma, 
USA). The absorbance was measured at 630 nm using 
ELISA microplate reader. We employed light microscopy 
method as a qualitative assay to investigate the anti-biofim 
activity of plant extract against C. albicans. The C. albicans 
biofilms were prepared as previously described (26). 
Thereafter, the media were discarded and coverslips were 
washed twice by PBS and viewed with a light microscope 
(Leica, DMRA II, Germany). 
qRT-PCR analysis of Candida albicans hypha-specific 
gene
A suspension containing different concentrations of 
antifungal  agents and 1×106   cells/mL of C. albicans 
ATCC 10231 were prepared as previously described (26). 
Total RNA was extracted from biofilm sample using the 
RNeasy Mini Kit (Qiagen, Hilden, Germany) according 
to the manufacturer’s instructions. The quantity and 
purity of the isolated RNA were measured by Nano Drop 
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Spectrophotometer ND-1000 (NanoDrop Technologies 
Inc., Wilmington, DE) and its integrity was checked on 
formaldehyde-denaturing agarose gel electrophoresis. 
To avoid DNA contamination, the RNA samples were 
treated with RNAse-free DNase I (Fermentas), according 
to manufacturer’s protocol. Single stranded cDNA was 
synthesized from 0.5 µg total RNA using Moloney-Murine 
Leukemia Virus reverse transcriptase (Fermentas, USA). 
C. albicans hypha-specific gene HWP1 was amplified 
from the synthesized cDNA with primer as described 
by Khodavandi et al (26). The amplification condition 
contained 26 cycles and PCR products were performed by 
gel electrophoresis and visualized via Molecular Imager Gel 
Doc XR System (Bio-Rad, USA). The PCR products were 
quantitated in terms of intensity of bands by comparing 
to known standard volumes (concentration of DNA mass 
standard [MassRuler Low Range DNA Ladder, Ready-to- 
Use, Fermentas]) according to manufacturer’s operating 
instructions of Quantity One 1-D Analysis software 
(Bio-Rad, USA, version 4.6.5). The PCR products were 
purified using the QIAquick Gel Extraction Kit (Qiagen). 
The identity of the purified product was confirmed by 
sequencing analysis (First BASE Laboratories Sdn. Bhd., 
Malaysia). The sequence similarity was queried via 
GenBank database in the NCBI by BLASTN (27).
Data analysis 
Three technical replicates in 2 independent assays were 
performed for each test. Results are expressed as mean 
value ± standard deviation (SD) and analyzed by using the 
software SPSS 20.0 for windows (SPSS Inc. Chicago, IL, 
USA). 
Results
Effect of Malva sylvestris, Dorema aucheri, Ferulago 
angulata and Citrullus colocynthis on growth of Candida 
albicans and Candida krusei
In order to identify inhibitors of growth of C. albicans 
and C. krusei isolates we performed a primary screen 
using different part of M. sylvestris, D. aucheri, F. angulata 
and C. colocynthis extracts. As a screening assay, we 
employed antifungal disk diffusion susceptibility test. Our 
initial screen tested the effect of exposure to 20, 50 and 
100 µg/mL of each of the tested extracts on C. albicans 
and C. krusei isolates. From these results we noticed that 
ethanol extract of M. sylvestris root was largely represented 
antifungal activity among the tested extracts. This study 
demonstrated various degrees of the antifungal potency of 
the aqueous and ethanol extracts of the different parts of 
plants against C. albicans and C. krusei. Table 1 shows the 
antifungal activity (assessed in terms of inhibition zone) 
of the tested extracts against C. albicans and C. krusei 
at concentration of 100 µg/mL. Results from primary 
screen were subjected to quantitative assay using broth 
microdilution antifungal susceptibility test. Table 2 shows 
the MIC values of tested extracts for C. albicans and C. 
krusei. Ethanol extract of M. sylvestris root was the most 
potent; with an MIC of 0.78 mg/mL against C. albicans 
and C. krusei. Aqueous extract of M. sylvestris leaf had 
inhibitory activity against C. albicans and C. krusei.
Table 1. Antimicrobial activities of Malva sylvestris, Dorema aucheri, Ferulago angulata and Citrullus colocynthis extracts against isolates 
of Candida albicans and Candida krusei at a concentration of 100 mg/mL
Tested extracts/Isolates Ca-1  Ca-2 Ca-3 Ck-1 Ck-2
M. sylvestris
Ethanol extract
Leaf 6.00 ± 0.00 6.00 ± 0.00 7.40 ± 0.57 7.38 ± 0.57 6.00 ± 0.00
Stem 6.00 ± 0.00 6.00 ± 0.00 7.21 ± 0.34 6.00 ± 0.00 6.00 ± 0.00
Root 7.89 ± 0.73 7.76 ± 0.73 6.45 ± 0.73 7.53 ± 0.73 6.00 ± 0.00
Aqueous extract
Leaf 6.35 ± 0.62 7.88 ± 0.62 6.00 ± 0.00 6.94 ± 0.62 6.00 ± 0.00
Stem 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
Root 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
D. aucheri
Ethanol extract
Leaf 6.00 ± 0.00 7.85 ± 0.55 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
Stem 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
Root 6.44 ± 0.22 6.44 ± 0.22 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
Aqueous extract
Leaf 6.55 ± 0.55 7.27 ± 0.55 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
Stem 6.00 ± 0.00 6.65 ± 0.34 7.05 ± 0.34 6.00 ± 0.00 6.00 ± 0.00
Root 6.44 ± 0.22 6.37 ± 0.44 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
F. angulata
Ethanol extract
Leaf 6.63 ± 1.43 6.00 ± 0.00 6.38 ± 0.11 6.00 ± 0.00 6.00 ± 0.00
Stem 6.00 ± 0.00 6.44 ± 1.43 7.15 ± 0.43 6.00 ± 0.00 6.00 ± 0.00
Root 6.00 ± 0.00 6.30 ± 0.53 7.25 ± 0.53 6.00 ± 0.00 7.58 ± 0.53
Aqueous extract
Leaf 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
Stem 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
Root 6.94 ± 0.27 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
C. colocynthis
Ethanol extract
Skin of fruit 7.21 ± 0.30 7.10 ± 0.40 6.84 ± 0.40 6.99 ± 0.40 6.00 ± 0.00
Seed 6.50 ± 0.11 6.54 ± 0.15 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
Aqueous extract
Skin of fruit 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00 6.00 ± 0.00
Seed 6.00 ± 0.00 6.00 ± 0.00 6.40 ± 0.98 6.00 ± 0.00 6.00 ± 0.00
Fluconazole 33.01 ± 0.01 32.09 ± 0.11 33.11 ± 0.21 33.31 ± 0.22 32.00 ± 0.13
Ca: Clinical isolates of C. albicans; Ck: Clinical isolates of C. krusei.
Data are means ± standard deviation of three independent experiments.
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Effect of ethanol extract of Malva sylvestris root on Candida 
albicans biofilm
On the basis of these analyses, we selected ethanol extract 
of M. sylvestris root as the most potent antifungal one 
for further biofilm-inhibitory properties. Findings from 
the biofilm-inhibitory properties of ethanol extract of 
M. sylvestris root on growth of C. albicans ATCC 10231 
exhibited significant reduction in biofilm growth (P < 0.05) 
compared to fluconazole-treated and also growth control 
cells. As shown in Table 3, the antifungal agents could 
significantly (P < 0.005) reduce the C. albicans biofilm. 
Treatments with the ethanol extract of M. sylvestris root 
Table 2. Relative MIC values of Malva sylvestris, Dorema aucheri, Ferulago angulata and Citrullus colocynthis extracts against isolates of Candida 
albicans and Candida krusei
Tested extracts/Isolates Ca-1 Ca-2 Ca-3 Ck-1 Ck-2 Tested extracts/Isolates Ca-1 Ca-2 Ca-3 Ck-1 Ck-2
*M. sylvestris
Ethanol 
extract
Leaf
MIC80 - - 12.5 6.25 -
*F. angulata
Ethanol
extract
Leaf
MIC80 1.56 - 3.12 - -
MIC50 - - 0.78 0.047 - MIC50 0.047 - 0.047 - -
Stem
MIC80 - - 6.25 - - Stem
MIC80 - 3.12 6.25 - -
MIC50 - - 0.19 - - MIC50 - 0.39 0.095 - -
Root
MIC80 0.78 0.78 0.78 0.78 - Root
MIC80 - 1.56 3.12 - -
MIC50 0.19 0.19 0.047 0.047 - MIC50 - 0.19 0.39 - -
Aqueous 
extract
Leaf
MIC80 3.12 25 - 3.12 -
Aqueous 
extract
Leaf
MIC80 - - - - -
MIC50 0.19 0.39 - 0.39 - MIC50 - - - - -
Stem
MIC80 - - - - - Stem
MIC80 - - - - -
MIC50 - - - - - MIC50 - - - - -
Root
MIC80 - - - - - Root
MIC80 3.12 - - - -
MIC50 - - - - - MIC50 0.39 - - - -
*D. aucheri
Ethanol
extract
Leaf
MIC80 - 12.5 - - -
*C. colocynthis
Ethanol
extract
Skin of 
fruit
MIC80 6.25 6.25 6.25 6.25 -
MIC50 - 0.39 - - - MIC50 0.39 0.047 0.047 0.047 -
Stem
MIC80 - - - - - Seed
MIC80 3.12 3.12 - - -
MIC50 - - - - - MIC50 0.047 0.047 - - -
Root
MIC80 6.25 6.25 - - -
Aqueous 
extract
Skin of 
fruit
MIC80 - - - - -
MIC50 0.047 0.047 - - - MIC50 - - - - -
Aqueous 
extract
Leaf
MIC80 6.25 25 - - - Seed
MIC80 - - 100 - -
MIC50 0.095 0.19 - - - MIC50 - - 0.19 - -
Stem
MIC80 - 3.12 6.25 - - **Fluconazole
MIC80 1 4 1 32 32
MIC50 - 0.39 0.095 - - MIC50 0.5 2 0.5 16 16
Root
MIC80 6.25 6.25 - - -
MIC50 0.095 0.047 - - -
*mg/mL; **μg/mL.
Ca: Clinical isolates of C. albicans; Ck: Clinical isolates of C. krusei.
Data are means ± standard deviation of three independent experiments.
Table 3. CV assays results for biofilm-associated Candida albicans 
ATCC 10231 treated with antifungal agents in different concentration 
based on MIC
Concentration of 
antifungal agents
Means absorbance at 630  nm ± SD
Ethanol extract of M. sylvestris 
root*
Fluconazole**
¼ × MIC 1.19 ± 0.06a 0.22 ± 0.01a
½ × MIC 0.95 ± 0.07b 0.21 ± 0.01a
1 × MIC 0.63 ± 0.08c 0.19 ± 0.01a
2 × MIC 0.45 ± 0.07d 0.18 ± 0.00a
Untreated control 2.42 ± 0.00e 2.42 ± 0.00b
*mg/mL; **μg/mL.
a-e Means ± SD in a column with different superscript differ significantly 
(P < 0.005) using Duncan test. The results were performed in 3 
independent experiments.
at 1 MIC and 2 MIC doses were found to be effective in 
reducing biofilm formation in C. albicans ATCC 10231, 
whilst the fluconazole reduced biofilm formation at all 
concentrations. 
The ability of fluconazole and the ethanol extract of M. 
sylvestris root to prevent biofilm formation visually verified 
by microscopic examination. Light microscopy indicated 
that incubation in the presence of ethanol extract of M. 
sylvestris root and fluconazole led to a decrease in biofilm 
thickness and cellular density as compared with biofilms 
formed in the untreated control (Figure 1). Moreover, 
as shown in Figure 1, the ability of antifungal agents to 
reduce C. albicans biofilm formation occurred in a dose-
dependent manner.
Effect of ethanol extract of Malva sylvestris root on the 
expression of hypha-specific gene
Ethanol extract of M. sylvestris root down regulated 
the expression of the HWP1. Figure 2 exhibits the 
representative gel electrophoresis for RT-PCR products of 
HWP1 gene from C. albicans treated with ethanol extract 
of M. sylvestris root in different concentrations based 
on MIC. We found that the relative quantification of 
HWP1 expression displayed significant down-regulation 
(P < 0.05) compared to untreated control after treatment 
of C. albicans with ethanol extract of M. sylvestris root in 
different concentrations based on MIC (Figure 3). The 
fold changes relative to untreated control in terms of 
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HWP1 expression for ¼ MIC, ½ MIC, 1 MIC and 2 MIC 
of ethanol extract of M. sylvestris root were 0.58 ± 0.012, 
0.48 ± 0.006, 0.46 ± 0.006 and 0.31 ± 0.006, respectively. 
Figure 1. Light microscopic view of the antifungal effect of ethanol extract of Malva sylvestris root and fluconazole at different concentrations 
based on MIC on the Candida albicans ATCC 10231 after 24 hours. (A) Untreated control (B) ¼ MIC (C) ½ MIC (D) MIC (E)  2 MIC. 
Magnification ×40, Bar = 50 µm.
Figure 2. Expression analysis of HWP1 gene in Candida albicans 
ATCC 10231 biofilm treated with different concentrations of 
ethanol extract of Malva sylvestris root after 24 h. RT-PCR 
amplification products were separated by electrophoresis in 1.7% 
agarose and stained with ethidium bromid.
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Figure 3. Relative quantitation of HWP1 gene expression 
(normalized to house-keeping gene, actin) in Candida albicans 
ATCC 10231 biofilm treated with different concentrations of 
ethanol extract of Malva sylvestris root after 24 h. Data are 
means ± standard deviation from three independent experiments 
amplified in triplicates. 
The ability of ethanol extract of M. sylvestris root to 
reduce the expression level of HWP1 occurred in a dose-
dependent manner. The authenticity of the amplification 
products was verified by DNA sequencing. The sequences 
displayed high similarity analyzed via the non-redundant 
nucleotide sequences from GenBank and confirmed to 
have 99% identity with the respective gene sequences. 
Discussion
Candidiasis is now the third-to-fourth most hospital 
acquired infections, as this normal flora of humans 
causes opportunistic infections particularly in 
immunocompromised patients. These infections are 
frequently associated with the formation of biofilms, 
which contributes to unacceptable high mortality rates 
(28). Evidence from studies of formation of biofilm in 
Candida has demonstrated adherence of Candida to host 
cells surfaces and Hwp1 interfere with host cells surfaces 
for formation of the stable complexes (29). Based on 
current knowledge in developing novel approaches for the 
prevention and treatment of Candida biofilms, it appears 
that medicinal plants have benefits in the area of human 
health, particularly in the design of more efficient natural 
medicines and the development of new antimicrobial 
agents (3,10). Our data demonstrate that the different part 
of M. sylvestris, D. aucheri, F. angulata and C. colocynthis 
extracts possessed activity against C. albicans and C. 
krusei. This is consistent with previous observations that 
M. sylvestris, D. aucheri, F. angulata and C. colocynthis 
plants could exhibited antimicrobial activities (11-21).
The ethanol extract of M. sylvestris root possessed strong 
activity against C. albicans. The ethanol extract of M. 
sylvestris root was able to reduce biofilm formation in 
comparison with fluconazole. Several lines of evidence 
previously demonstrated the antifungal property of M. 
sylvestris against Candida species (11,12). The traditional 
use of M. sylvestris has been reported since a long-time 
ago and roots, shoots, leaves, flowers, fruits, and seeds 
are applied in the pharmaceutical industries. Active 
components in M. sylvestris such as amino acids and protein 
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derivatives, flavonoids, mucilages, phenol derivatives, 
enzymes (sulphite oxidase), coumarins, vitamin E, 
vitamin C, fatty acids and sterols, pigments (chlorophyll 
A, chlorophyll B, xanthophylls and carotenoids) and 
terpenoids, including monoterpenes, diterpenes, 
sesquiterpenes and norterpenes as well as other important 
pythochemicals possibly affect fungal infections (13,29-
33). Several studies have shown that flavonoids and 
other plant-derived polyphenolic compounds have free 
radical scavenging potential and antioxidant properties 
by single-electron transfer (30,32). Cushnie and Lamb 
(34) considered that flavonoids within plants account for 
the antifungal activities. The metal chelating properties 
of flavonoids and the ability to scavenge singlet oxygen, 
superoxide anions, peroxyl radicals, hydroxyl radicals 
and peroxynitrite suggest that they may play a role in 
biological activity (32). 
The mechanisms of the antimicrobial actions of plant-
derived polyphenolic compounds such as tannins may 
be related to the ability to inactivate microbial adhesins, 
enzymes and cell envelope transport proteins (35). The 
actions of plant natural products on biofilm eradication 
may involve the inhibition of cell accumulation, 
interrupting the biofilm structure, destruction of 
extracellular matrix, dissemination through the biofilm 
extracellular matrix and subsequent damage due to their 
powerful antimicrobial activities (36,37).
Our previous reports have shown a high efficacy of allicin 
and Allium ascalonicum to inhibit biofilm formation 
which was linked to down regulation of HWP1 in C. 
albicans (23,26). Meanwhile, our new findings have 
demonstrated that M. sylvestris could also significantly 
reduce the expression of HWP1 in C. albicans. The 
molecular mechanism of C. albicans in response to 
active components of M. sylvestris warrants further 
investigation. C. albicans biofilms constitute a threat to 
successful antifungal treatment (38). It is thus conceivable 
that suppression of the yeast-to-hypha transition in C. 
albicans by ethanol extract of M. sylvestris root could be a 
viable antifungal strategy.
Conclusion 
In conclusion, ethanol extract of M. sylvestris root 
exhibits anti-biofilm effect selectively against C. albicans. 
In addition, the non-toxic nature of medicinal plants 
to human cells may have clinical relevance as a new 
method to treat candidiasis. Further studies are required 
to determine whether the anti-biofilm effect of ethanol 
extract of M. sylvestris root is applicable in clinical settings.
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